Similar articles

• Nilutamide response after flutamide failure in post-orchiectomy progressive prostate cancer.

  Eastham JA, Sartor O. Eastham JA, et al. J Urol. 1998 Mar;159(3):990. J Urol. 1998. PMID: 9474206 No abstract available.
• The place and the results of monotherapy.

  Bonnet P. Bonnet P. Acta Urol Belg. 1998 May;66(2):11-5. Acta Urol Belg. 1998. PMID: 9633120 Review. No abstract available.
• [Neoadjuvant hormonal therapy for prostate cancer].

  Miyakita H. Miyakita H. Nihon Rinsho. 2005 Feb;63(2):309-13. Nihon Rinsho. 2005. PMID: 15714984 Japanese.
• Antiandrogen monotherapy in the management of advanced prostate cancer.

  Kaisary AV. Kaisary AV. Eur Urol. 1997;31 Suppl 2:14-9; discussion 24-7. doi: 10.1159/000474543. Eur Urol. 1997. PMID: 9074906
• Which is the optimal antiandrogen for use in combined androgen blockade of advanced prostate cancer? The transition from a first- to second-generation antiandrogen.

  Sarosdy MF. Sarosdy MF. Anticancer Drugs. 1999 Oct;10(9):791-6. doi: 10.1097/00001813-199910000-00001. Anticancer Drugs. 1999. PMID: 10587288 Review.